However, the recommended biochemical investigation for the monitoring of the two drugs remains to be chromogenic anti-Xa heparin assay for EX and FD, which was not done due to the resource limited settings. The correlation of these biochemical parameters (platelet aggregation, bleeding time and prothrombin time and international normalized ratio) with the haemorrhagic events could not be studied, which remains the limitation of the current study. The study was of a short duration, with less number of patients, without evaluating the long-term effects on mortality outcome and inability to include patients with ST-elevation MI which may have altered the outcome of the study